Cottini Marcello, Poto Remo, Bhattacharjee Atanu, Galant Stanley, Lipworth Brian, Gaillard Erol A, Greig Robert, Berti Alvise, Lombardi Carlo, Menzella Francesco, Ventura Laura, Comberiati Pasquale, Chan Rory
Allergy and Pneumology Outpatient Clinic, Bergamo, Italy.
Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy; Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
Respir Med. 2025 Aug;244:108180. doi: 10.1016/j.rmed.2025.108180. Epub 2025 May 27.
The preserved ratio impaired spirometry (PRISm) phenotype is characterized by a maintained FEV/FVC ratio ≥70 but an abnormal FEV<80 % predicted. Small airways dysfunction (SAD) is common amongst asthmatics and is associated with poorer clinical outcomes. SAD can be assessed using oscillometry as resistance between 5 and 20Hz (Rrs5-20), reactance at 5Hz (X5) and area under the reactance curve (AX). We aimed to investigate the prevalence of PRISm and its relationship with SAD in all severities of asthma with the primary outcome of annual exacerbation rate.
Data from the Oscillometry Asthma Registry comprising 937 adults with GINA-defined persistent asthma were retrospectively collected from two specialized asthma centres in UK and Italy. Multivariate analyses were performed using binary logistic regression to obtain adjusted odds ratios for the association between PRISm and exacerbation frequency and symptom control.
PRISm had a 19.6 % prevalence in moderate-to-severe asthma and was associated with a greater likelihood of ≥1 exacerbation [OR 95 %CI 3.00 (1.80,5.00) p < 0.001], ≥2 exacerbations [4.00 (1.86,8.59) p < 0.001] and uncontrolled symptoms [14.04 (4.87,40.50) p < 0.001] compared to patients with normal spirometry. Conversely, patients with PRISm were prescribed significantly lower ICS doses and had fewer exacerbations compared to those with airway obstruction.
The PRISm asthma phenotype is associated with greater exacerbation frequency, poorer symptom control and a higher SAD prevalence compared to patients with normal spirometry. Future research should focus on longitudinal follow-up to confirm the progression of PRISm to obstructive patterns and assess potential therapeutic interventions to modify this trajectory.
肺功能测定值保留的气流受限(PRISm)表型的特征是FEV/FVC比值维持在≥70%,但FEV低于预测值的80%。小气道功能障碍(SAD)在哮喘患者中很常见,且与较差的临床结局相关。SAD可通过振荡法进行评估,即测量5至20赫兹之间的阻力(Rrs5-20)、5赫兹时的电抗(X5)以及电抗曲线下面积(AX)。我们旨在调查所有严重程度哮喘中PRISm的患病率及其与SAD的关系,主要结局指标为年加重率。
从英国和意大利的两个专业哮喘中心回顾性收集了来自振荡法哮喘登记处的937名符合全球哮喘防治创议(GINA)定义的持续性哮喘成年患者的数据。使用二元逻辑回归进行多变量分析,以获得PRISm与加重频率及症状控制之间关联的调整比值比。
在中重度哮喘中,PRISm的患病率为19.6%,与肺功能正常的患者相比,PRISm患者发生≥1次加重的可能性更大[比值比(OR)95%置信区间(CI)为3.00(1.80,5.00),p<0.001],≥2次加重的可能性更大[4.00(1.86,8.59),p<0.001],且症状控制不佳的可能性更大[14.04(4.87,40.50),p<0.001]。相反,与气道阻塞患者相比,PRISm患者吸入糖皮质激素(ICS)的剂量显著更低,且加重次数更少。
与肺功能正常的患者相比,PRISm哮喘表型与更高的加重频率、更差的症状控制以及更高的SAD患病率相关。未来的研究应侧重于纵向随访,以确认PRISm向阻塞性模式的进展,并评估改变这一进程的潜在治疗干预措施。